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Dr. Clifton Fletcher Mountain died in Los Angeles on
April 19, 2007 after a prolonged illness. Dr. Mountain was a
leader in lung cancer staging and one of the founders of the
International Association for the Study of Lung Cancer
(IASLC).
Dr. Mountain was born in Toledo, Ohio on April 15,
1924. He received his undergraduate degree from Harvard
College and attended Harvard University Graduate School of
Arts and Sciences. He received his MD degree from Boston
University School of Medicine and completed postgraduate
training at the University of Chicago and the University of
Texas–MD Anderson Cancer Center. He was a First Lieuten-
ant and damage control officer in the submarine and destroyer
escort service in the United States Navy. He received six
decorations for exemplary service in WWII in the Pacific
theater of operations. Dr. Mountain began his professional
career as executive assistant to the vice president and dean of
Boston University. He subsequently was chairman of the
office of statistical research, director of the computer center at
Boston University, and research consultant to the Department
of Public Health, Commonwealth of Massachusetts.
In 1961 he moved to Houston. His appointments in-
cluded professor of surgery at the University of Texas School
of Medicine at Houston and professor of surgery at the
University of Texas–MD Anderson Cancer Center. He was
head of the thoracic oncology program and chairman of the
department of thoracic surgery during this time. Dr. Mountain
also was senior consultant for the Houston Thorax Institute
and consultant for the Texas Heart Institute. In 1964, Dr.
Mountain and Dr. David Carr, a medical oncologist at the
Mayo Clinic, realized the importance of a staging system for
lung cancer; no such system existed at that time. They also
realized that previously published classification schemes spe-
cifically for lung cancer were found wanting, and none had
received wide acceptance. Together, Dr. Mountain and Dr.
Carr developed the first TNM staging system for lung cancer,
supported by a large database of clinical material. This work
was undertaken under the auspices of the Task Force on Lung
Cancer of the American Joint Committee on Cancer Staging
and End Results Reporting (AJCC) and was subsequently
adopted by the AJCC.
Dr. Mountain continued to refine this system through-
out the rest of his career, and his staging system became the
standard worldwide in any discussion of lung cancer. Recog-
nizing the need to coordinate international efforts in lung
cancer research, Dr. Mountain was one of the founders of the
IASLC in 1973. He was elected the third president of IASLC
in 1977, and he organized the First International Congress in
1978 in Hilton Head, South Carolina. He remained active in
IASLC throughout his career, and he received the President’s
Award (1994) and the Distinguished Achievement Award
(1991) for his service and contributions to IASLC.
During his long career of more than 35 years at the MD
Anderson Cancer Center and afterwards at UCSD, Dr. Moun-
tain was a popular lecturer and consultant in nations through-
out the world. He brought his statistical expertise to his
chosen field of medicine when he served as chairman and
project director of the program in biomathematics at the
University of Texas Graduate School of Biomedical Sciences
in Houston. He carried the message of the multidisciplinary
care for lung cancer developed at MD Anderson to physicians
and researchers at all levels of endeavor—from sophisticated
specialized teaching institutions to community cancer clinics.
Pursuing his interest in diagnosis and surgical instru-
mentation, Dr. Mountain introduced surgical stapling devices
to the southwestern United States, promoting the use of
instruments given to him while he visited the Soviet Union as
a delegate under President Richard Nixon’s detente program.
He also introduced the technique of mediastinoscopy in the
Southwest, based on the work of Eric Carlens in Sweden. On
the basis of his observations, when he served as a delegate on
the U.S. Scientific Mission to Japan, Dr. Mountain took
notice of that nation’s work in the application of photobiol-
ogy and use of laser technology. He pursued early experi-
mental work in the use of autofluorescence in the diagnosis
and treatment of lung cancer. In 1979, Dr. Mountain’s idea to
establish a multidisciplinary clinic that brought together treat-
ment and patient care specialists to more efficiently battle the
growing problem of lung cancer became the institution’s first
thoracic oncology program. Throughout his career, Dr.
Mountain dedicated a major research effort to developing
staging classifications for lung cancer, supported by carefully
collected data. From this work, he promoted accurate, repro-
ducible staging as a baseline for clinical research projects.
This work produced international agreement on standardized
definitions for anatomic factors vital to treatment selection,
end-result reporting, and communication of knowledge about
lung cancer.
After his retirement from the MD Anderson Cancer
Center in 1996, Dr. Mountain continued his lifelong commit-
ment to excellence in the diagnosis and treatment of patients
with thoracic cancer while he served as clinical professor of
surgery in the division of cardiothoracic surgery at the Uni-
versity of California at San Diego. He and his wife, Merel,
enjoyed living in La Jolla and sailing in the Pacific aboard
their sloop, Volare. He was a valued lecturer at grand rounds
at the Scripps Clinic and Research Foundation, the Postgrad-
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uate Assembly in Surgery, Hoag Memorial Hospital, and
Scripps Memorial Hospital, among others. Dr. Mountain
continued to participate in international scientific conferences
in Canada, England, South America, Greece, Italy, Ireland,
and Japan throughout the remainder of his life.
Dr. Mountain established the Clifton F. Mountain
Foundation for Research and Education in Lung Cancer, and
from this resource he promoted a staging classification of
lung cancer and its applications for treatment selection and
evaluation of results of treatment approaches and programs.
Along with colleagues, he published the illustrative staging
manual, A Handbook for Staging, Imaging and Lymph Node
Classification in Lung Cancer, which was distributed world-
wide by Bristol-Meyers Squibb, and which was published
online as a teaching vehicle for residents in thoracic surgery
at the Johns Hopkins Medical School. His collected works
from 1951 to 2004 were published by the foundation in 2007.
Dr. Mountain gave freely of his time to participate in
numerous scientific and administrative committees of na-
tional and international organizations. He received many
awards, including the Rudolph Nissen Medal for “Contribu-
tions to Thoracic Surgery and Service Rendered to the Cause
of Science: German Society for Thoracic and Cardiovascular
Surgery” (1998); the Distinguished Alumnus Award, Boston
University School of Medicine (1992); the Distinguished
Service Award, The University of Texas–MD Anderson Can-
cer Center at Houston (1990), the Medal of the National
Cancer Institute of Japan (1985); the Enrique M. Garcia
Memorial Medal from the Philippine College of Surgeons
(1982); the title of Honorary Director, Chilean Society for
Diseases of the Thorax (1982); and the Award of the Soviet
Academy of Science (1977).
In the United States and in many countries throughout
the world, Dr. Mountain was a visiting professor and lecturer,
and he participated in local, national, and international sci-
entific meetings and congresses. He gave over 450 scientific
presentations, with appointments as visiting professor and
honored guest lecturer on over 145 occasions, including 117
lectureships in 22 foreign countries and in 28 educational
institutions in the United States. A dedication to professional
and lay education is reflected in his publications, which
include 73 chapters in books and 158 articles in scientific
journals, some still in press. Dr. Mountain also served on the
editorial boards of a number of U. S. and foreign journals.
Many friends will remember Dr. Mountain’s often
quoted words: “Medicine is like sailing... part art and part
science. When man first gained an understanding of sails and
harnessed the power of the wind, he extended the limits of
travel and measurably increased his capacity for collecting
knowledge. In so doing he learned more about the very power
that was moving him.” Dr. Mountain is survived by his wife
Merel, three children, three stepchildren, and four grandchil-
dren. The Clifton F. Mountain Foundation continues his
work. He will be missed greatly and remembered for his
remarkable, unique, and invaluable contributions to oncology
and surgery.
I would like to thank Mrs. Merel Mountain and Dr. David
Carr for their contributions.
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